<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Large molecular systems landscape uncovers T cell trapping in human skin cancer</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-01-13">13 January 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Reyk</forename><surname>Hillert</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Medical Faculty</orgName>
								<orgName type="laboratory">Molecular Pattern Recognition Research Group</orgName>
								<orgName type="institution">OvG University Magdeburg</orgName>
								<address>
									<addrLine>Leipziger Straße 44</addrLine>
									<postCode>D-39120</postCode>
									<settlement>Magdeburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anne</forename><surname>Gieseler</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Medical Faculty</orgName>
								<orgName type="laboratory">Molecular Pattern Recognition Research Group</orgName>
								<orgName type="institution">OvG University Magdeburg</orgName>
								<address>
									<addrLine>Leipziger Straße 44</addrLine>
									<postCode>D-39120</postCode>
									<settlement>Magdeburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department for Structural Cell Biology</orgName>
								<orgName type="department" key="dep2">Center for Biological Systems Analysis (ZBSA)</orgName>
								<orgName type="institution">Albert-Ludwigs-University</orgName>
								<address>
									<addrLine>Habsburger Straße 49</addrLine>
									<postCode>D-79104</postCode>
									<settlement>Freiburg, Freiburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><surname>Krusche</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Medical Faculty</orgName>
								<orgName type="laboratory">Molecular Pattern Recognition Research Group</orgName>
								<orgName type="institution">OvG University Magdeburg</orgName>
								<address>
									<addrLine>Leipziger Straße 44</addrLine>
									<postCode>D-39120</postCode>
									<settlement>Magdeburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Daniel</forename><surname>Humme</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Dermatology, Venerology and Allergology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Charitéplatz 1</addrLine>
									<postCode>D-10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hans-Joachim</forename><surname>Röwert-Huber</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Dermatology, Venerology and Allergology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Charitéplatz 1</addrLine>
									<postCode>D-10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wolfram</forename><surname>Sterry</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Dermatology, Venerology and Allergology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Charitéplatz 1</addrLine>
									<postCode>D-10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><surname>Walden</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Dermatology, Venerology and Allergology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Charitéplatz 1</addrLine>
									<postCode>D-10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Walter</forename><surname>Schubert</surname></persName>
							<email>walter.schubert@med.ovgu.de</email>
							<affiliation key="aff0">
								<orgName type="department">Medical Faculty</orgName>
								<orgName type="laboratory">Molecular Pattern Recognition Research Group</orgName>
								<orgName type="institution">OvG University Magdeburg</orgName>
								<address>
									<addrLine>Leipziger Straße 44</addrLine>
									<postCode>D-39120</postCode>
									<settlement>Magdeburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Human Toponome Project (HUTO)</orgName>
								<address>
									<addrLine>Margaretenstraße 20</addrLine>
									<postCode>D-81373</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Large molecular systems landscape uncovers T cell trapping in human skin cancer</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-01-13">13 January 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">A9B6E44B1AAEE02EE7507E0EF01070F2</idno>
					<idno type="DOI">10.1038/srep19012</idno>
					<note type="submission">Received: 11 June 2015 Accepted: 02 December 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:40+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Immune surveillance of tumour cells is an important function of CD8 T lymphocytes, which has failed in cancer for reasons still unknown in many respect but mainly related to cellular processes in the tumour microenvironment.</s><s>Applying imaging cycler microscopy to analyse the immune contexture in a human skin cancer we could identify and map 7,000 distinct cell surface-associated multi-protein assemblies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The resulting combinatorial geometry-based high-functional resolution led to discovery of a mechanism of T cell trapping in the epidermis, which involves SPIKE, a network of suprabasal keratinocyte projections piercing and interconnecting CD8 T cells. It appears initiated by clusters of infrabasal T and dendritic cells connected via cell projections across a fractured basal lamina to suprabasal keratinocytes and T lymphocytes.</head><p><s>T lymphocytes have important functions in the immune-mediated control of tumour cells <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref> but in manifest cancer they appear incapacitated within the tumour microenvironment for, in many aspects, still elusive reasons <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref> .</s><s>Besides T cells and cancer cells, the tumour microenvironment comprises other cellular and non-cellular components such as cells of mesenchymal origin and molecules of the extracellular matrix that all influence course and outcome of the malignancies <ref type="bibr" target="#b20">21</ref> .</s><s>Over the past two decades a wealth of information has been acquired on various factors that may interfere with effective anti-tumour immune responses such as Tregs, cytokines, tumour matrix, immunological checkpoint receptors (PD-1, CTLA-4) and others <ref type="bibr" target="#b21">22</ref> .</s><s>Nonetheless, the highly diverse and varied interactions of the components in the tumour microenvironment that often support cancer development are in major aspects not understood.</s><s>Such lack of understanding may in parts explain the high failure rates of new drugs <ref type="bibr" target="#b22">23</ref> targeting one or several components of the microenvironment.</s><s>Like other biological systems <ref type="bibr" target="#b23">24</ref> , the tumour microenvironment appears robust and is not easily upset as long as the critical interactions and corresponding nodes of robustness are not targeted and inactivated.</s><s>The high attrition rate of anti cancer drugs <ref type="bibr" target="#b22">23</ref> suggests that pharmaceutical development guided by model studies does not sufficiently reflect the disease processes inside human tissues.</s><s>This emphasizes the need for methods for the detection and analysis of disease mechanisms directly in situ.</s><s>As discussed previously <ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26</ref> , information on the spatiotemporal arrangements of molecules and cells in tissues are required for proper diagnosis and essential for an understanding the pathological processes.</s></p><p><s>To address directly the topology of multi-component systems in human skin cancer tissue, we employed imaging cycler microscopy (ICM) <ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26</ref> to analyse the immune contexture in skin tissue of the cutaneous CD4 T cell lymphoma Mycosis fungoides (for details of the clinicopathological features see Supplementary Figure <ref type="figure" target="#fig_0">1</ref>).</s><s>ICM is an automated technique that runs repetitive cycles of fluorescence labelling of biomolecules followed by imaging and bleaching in situ, and is capable of co-mapping the hierarchical combinatorial structure of many thousand distinct biomolecular assemblies, termed the toponome <ref type="bibr" target="#b26">27</ref> .</s><s>Toponome-based search for biomarkers and drug targets with the identification of lead proteins that control protein network topology and function in situ <ref type="bibr" target="#b26">27</ref> has been validated experimentally <ref type="bibr" target="#b27">28</ref> and clinically <ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b29">30</ref> .</s><s>Here we used ICM to address directly the topology of multi-component systems in the human skin cancer Mycosis fungoides, a cutaneaous CD4 T cell lymphoma.</s><s>ICM-based combinatorial geometry of more than 7,000 distinct cell surface-associated biomolecular assemblies  <ref type="figure">d,c</ref>).</s><s>A partial list of color decoding is given in Supplementary disclosed a hitherto unknown multicellular structure, which we then dissected spatially using a real-time virtual anatomical slicing technique.</s><s>This approach revealed direct insight into an unexpected structure and mechanism of mechanical trapping of suprabasal non-tumour CD8 T cells through keratinocyte-mediated piercing, interconnecting and thus fixing these cells with infrabasal cells in the dermis.</s><s>This entire multicellular assembly constitutes a systems-robustness node protecting the tumour from cytotoxic T cell attack.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Mycosis fungoides (MF) is a non-Hodgkin T cell lymphoma in human skin of unknown aetiology that mostly, as in the case studied here, involves fully differentiated malignant CD4 T cells <ref type="bibr" target="#b30">31</ref> (Supplementary Figure <ref type="figure" target="#fig_0">1</ref>).</s><s>To understand the immune mechanisms in this disease and the complex cellular interactions in the tumour microenvironment outside the CD4 tumour cell clusters we applied parameter-unlimited ICM <ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26</ref> for dissecting cell surface-associated molecular systems likely to provide insight into cellular interaction patterns in the tumour tissue.</s><s>ICM was performed with a robotic system programmed to run repetitive cycles of staining, imaging and bleaching of a FITC-conjugated tag library (for the mapped 25 distinct biomolecules see Supplementary Table <ref type="table">1</ref>) to collect z-stack images of every detected protein of a MF tissue section placed on the stage of the ICM epifluorescence scanning table <ref type="bibr" target="#b31">32</ref> (see methods section).</s><s>The resulting combinatorial molecular phenotypes (CMPs) per voxel were assembled as frequency matrix (Supplementary Table <ref type="table">2 and 3</ref>) sorted by motifs with lead proteins present in all CMPs of the respective motif, and then mapped to and visualized at their tissue locations (exemplified in Supplementary Figure <ref type="figure" target="#fig_1">2</ref>) as previously described <ref type="bibr" target="#b31">32</ref> .</s><s>In all, we found motifs together comprising 7,161 CMPs (Supplementary Table <ref type="table">2</ref>).</s></p><p><s>To investigate the CMPs directly in their tissue context we followed a systems-biological top down approach 33 from transcellular to subcellular visualization of tissue features, applying stepwise visualization of all or fractions of the CMPs as combinatorial geometric structures.</s><s>We then applied virtual anatomical sectioning guided by the discovered geometric structures <ref type="bibr" target="#b25">26</ref> .</s><s>In a first step, we extracted the most prominent proteins, lead proteins <ref type="bibr" target="#b24">25</ref> , from the identified CMPs.</s><s>Then we visualized the locations of the corresponding CMPs and their lead proteins simultaneously at 3D, exemplified for 3,213 CMPs in Fig. <ref type="figure" target="#fig_7">1a,d</ref>, respectively (Supplementary Table <ref type="table">3</ref>).</s><s>The colours are partially decoded in Supplementary Figure <ref type="figure" target="#fig_1">2</ref>. The most prominent lead proteins were extracted and co-visualized directly in the frozen skin tissue section of MF (Fig. <ref type="figure" target="#fig_7">1b,c,d respectively</ref>).</s><s>This finally exposed the molecular details of cellular interactions and disease-specific CMP arrangements (Fig. <ref type="figure" target="#fig_7">1e-k</ref>) (Supplementary Video 1).</s></p><p><s>As result, we identified a multicellular assembly of five cell types (Fig. <ref type="figure" target="#fig_7">1a</ref>; Cells 1 through 5), three located in the dermis (Fig. <ref type="figure" target="#fig_7">1a</ref>, Cells 3 to 5), two in the epidermis (Fig. <ref type="figure" target="#fig_7">1a</ref>, Cells 1 and 2).</s><s>The cells are interconnected by a cell projection extending from the dermal cell cluster to the cells 1 and 2 in the epidermis, penetrating the basal lamina (BL) (Fig. <ref type="figure" target="#fig_7">1a</ref>, arrowhead), an extracellular matrix structure naturally separating dermis from epidermis, which in this case of MF, however, appears distorted.</s><s>Henceforth we call this entire multicellular structure SPIKE (a multicellular apparatus spiking the BL).</s><s>Major aspects of SPIKE (Cells 3,4,5 plus the trans-BL cell extension) are resolved by the composition of cell surface-associated CMPs, which appear to be building blocks or coherent distinctive multi-molecular components of SPIKE´s cell surface organization (Fig. <ref type="figure" target="#fig_7">1a</ref>, partial colour decoding list in Supplementary Figure <ref type="figure" target="#fig_0">1</ref>).</s><s>These CMPs have HLA-DQ as common lead protein combined with other, variably co-mapped cell surface proteins (Fig. <ref type="figure" target="#fig_7">1i</ref>) while others are always absent.</s><s>Together this defines a CMP motif, a three symbol code with a lead protein (LP), variably associated proteins (wild cards), and absent proteins (0) <ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b31">32</ref> .</s><s>In respect to SPIKE, Motif 1 (M1, Fig. <ref type="figure" target="#fig_7">1l</ref>) selectively characterizes the SPIKE structure as visualized in Fig. <ref type="figure" target="#fig_7">1d</ref>.</s></p><p><s>Prominent feature of SPIKE is the presence of a large number of CMPs expressed along the supra-basal SPIKE´s cell extension (Fig. <ref type="figure" target="#fig_7">1a</ref>, arrow 1) compared to more extended spatial distributions of only few CMPs in the dermal cell components of SPIKE (Fig. <ref type="figure" target="#fig_7">1a</ref>, cells 3 to 5).</s><s>The suprabasal SPIKE cell extension projects between a cytokeratin-expressing epidermal cell (keratinocyte) (Fig. <ref type="figure" target="#fig_7">1a</ref>, CK, asterisk, Cell 1) and a CD3 + CD8 + non-tumour T cell (Fig. <ref type="figure" target="#fig_7">1a</ref>, cell 2) apparently bridging the cell surfaces of these two cells.</s><s>This is supported by the spatial interrelationship of SPIKE's cell extension (Fig. <ref type="figure" target="#fig_7">1a</ref>, arrow 1), the keratinocyte (Fig. <ref type="figure" target="#fig_7">1a</ref>, cell 1) and the CD3 + CD8 + T cell (Fig. <ref type="figure" target="#fig_7">1a</ref>, cell 2).</s><s>T cells of the latter type are known to infiltrate MF tissue and exhibit anti-tumour cytotoxic activity <ref type="bibr" target="#b33">34</ref> but the ultimate clinical outcome suggests blocking mechanisms inside the tumour tissue <ref type="bibr" target="#b30">31</ref> .</s><s>By analyzing the contact sites of the different cell types as visualized by the combinatorial geometric structure (Fig. <ref type="figure" target="#fig_7">1a</ref>) with the suprabasal cell types (Fig. <ref type="figure" target="#fig_0">1</ref>, Cell 2), we identified a CMP structure apparently projecting from the cell extension (Fig. <ref type="figure" target="#fig_7">1a</ref>, arrow 1) into the CD3 + CD8 + T cell (Fig. <ref type="figure" target="#fig_7">1a</ref>, arrow 2).</s><s>We analyzed the interaction site in more detail by first extracting the lead protein HLA-DQ from Motif 1 (see above) and displaying it three-dimensionally (Fig. <ref type="figure" target="#fig_7">1d</ref>, magenta) together with the CD3 + CD8 + T cell (Fig. <ref type="figure" target="#fig_7">1d</ref>, Cell 2, brown).</s><s>This interaction site corresponds Fig. <ref type="figure" target="#fig_1">2</ref>; the complete CMP list in provided in Supplementary Table <ref type="table">2</ref>).</s><s>A long cell projection (arrow 1 in a) of Cells 3,4,5 extends from the dermis across the basal lamina (a, BL) into the epidermis where it is closely opposed to a CD8 + CD3 + T cell (Cell 2 in a,c,d; brown color in d) and a neighboring keratinocyte (Cell 1 in a,c,d).</s><s>(e) details of the suprabasal part of this structure pictured from different angles (e,f,g,h).</s><s>A cytokeratincontaining cell projection (CK) extending from the keratinocyte (e, arrow) (Cell 1) projects through the CD3 + CD8 + T cell surface (compare (h) showing CK in green and (g) the same without CK).</s><s>(k) transverse virtual anatomical slicing across the CD8 + CD3 + T cell (Cell 2 in j).</s><s>Keratinocyte projection (CK) penetrates the T cell interior (arrow).</s><s>(i) list of the co-mapped molecules (detailed in Supplementary Table <ref type="table">1</ref>).</s><s>(l) CMP motifs specific for SPIKE as a whole (Motif M1) (for details see the complete functional CMP linkage map in Supplementary Table <ref type="table">2</ref>).</s><s>Supplementary Video 1 illustrates the active process of spatial dissection of the SPIKE´s structures.</s><s>Bars: in (a-d,j): 10 μ m; in (f,g,k): 1 μ m.</s></p><p><s>to the combinatorial geometry CMP structure in Fig. <ref type="figure" target="#fig_7">1a</ref>.</s><s>Both modes of visualizing SPIKE were aligned with the corresponding site in the phase-contrast image of the cryosection (Fig. <ref type="figure" target="#fig_7">1b</ref>, boxed area, magnified in 1c).</s><s>Next, we further inspected the interaction site shown in Fig. <ref type="figure" target="#fig_0">1</ref> (arrow 2) by visualizing the details in the tilted image of the structure (Fig. <ref type="figure" target="#fig_7">1d</ref>, Cell 2) as shown in Fig. <ref type="figure" target="#fig_7">1f,g,h</ref>.</s><s>This revealed that Cell 2 (Fig. <ref type="figure" target="#fig_7">1f</ref>) co-localizes with a cytokeratin-containing extension of the neighboring keratinocyte (Fig. <ref type="figure" target="#fig_7">1e</ref>, arrow 1, CK).</s><s>In addition, these analyses revealed a roundish area devoid of CD3 and CD8 (Fig. <ref type="figure" target="#fig_7">1f,g</ref>, arrow) within the CD3 + CD8 + T cell surface (Fig. <ref type="figure" target="#fig_7">1f,g, brown color</ref>), leaving open whether this was due to circumscribed absence of CD3/CD8 or to a physical defect of the T cell membrane, or another structural abnormality of the cell surface.</s><s>To decide between these possibilities we applied virtual anatomical sectioning across the region and found a long cytokeratin-containing extension of the keratinocyte projecting (Fig. <ref type="figure" target="#fig_7">1e</ref>, arrow) into the CD3/CD8-devoid T cell surface area (Fig. <ref type="figure" target="#fig_7">1g  arrow, h</ref>) where it extends into the T cell (Fig. <ref type="figure" target="#fig_7">1k arrow)</ref>.</s><s>Figure <ref type="figure" target="#fig_0">1</ref>(e) gives an overview of the interaction site visualizing only the most prominent proteins.</s><s>Following the route of the cytokeratin projection (Fig. <ref type="figure" target="#fig_7">1k</ref>, arrow), we identified an extended ramified network of cytokeratin-containing projections penetrating and crossing suprabasal CD8 + CD3 + T cells (Fig. <ref type="figure" target="#fig_1">2</ref>) apparently fixing them mechanically in the suprabasal region of the skin.</s><s>The traces of the keratinocyte projection cross-connecting the T cells are highlighted with white lines in Fig. <ref type="figure" target="#fig_1">2a-d</ref>.</s><s>Given the strictly intracellular location of cytokeratins in epidermal cells, it is likely that the cytokeratin-containing projections are ensheathed by cell membrane.</s><s>With the tag library used in this study, we were unable to identify this membrane; this notwithstanding the topological correlation of cytokeratin with epidermal cell structures shown in (Fig. <ref type="figure" target="#fig_7">1e</ref>, Cell 1; k) strongly suggests that intracellular cytokeratin is just a marker for an extended network of epidermal cell membrane projections.</s></p><p><s>Through the network of keratinocyte projections, the infiltrating T cells, many likely anti-tumour T cells, may be mechanically trapped at the suprabasal sites in situ.</s><s>This process is associated with and appears to be mediated by the BL-penetrating cell extension of SPIKE.</s><s>This hypothesis is supported by ICM data directly aligned as (i) threshold-based CMPs (Fig. <ref type="figure" target="#fig_3">3a,e</ref>), (ii) semitransparent 3D supramolecular assembly imaging (Fig. <ref type="figure" target="#fig_3">3c,d</ref>), and (iii) non-threshold based multi-protein profiling using real-time similarity mapping <ref type="bibr" target="#b34">35,</ref><ref type="bibr" target="#b35">36</ref> (Fig. <ref type="figure" target="#fig_3">3b</ref>) (Supplementary Video 2).</s><s>This synopsis reveals that the supramolecular organization of multicellular SPIKE is bipartite.</s><s>While the dermal part expresses a CD8 T cell motif in Cell 5 (Fig. <ref type="figure" target="#fig_3">3a</ref>,b, Cell 5) and a HLA-DQ motif in Cells 3 and 4 (Fig. <ref type="figure" target="#fig_3">3a</ref>, cells 3 and 4), only the HLA-DQ motif, not the CD8 motif (cell 5), is continued into the suprabasal cell extension of SPIKE (Fig. <ref type="figure" target="#fig_3">3e</ref>, partial color decoding list in Supplementary Figure <ref type="figure" target="#fig_1">2</ref>).</s><s>The large number of distinct CMPs on SPIKE´s suprabasal cell extension indicates a highly differentiated supramolecular organization at the cell surface membrane, apparently directly controlling the suprabasal cellular pathology.</s></p><p><s>Having SPIKE and the arrangement of the cells around SPIKE identified (A subbasal cluster of two CD8 + T cells and a dendritic cell-like cell extending SPIKE across the BL to a suprabasal cluster of a CD8 + T cell and a keratinocyte that fixes this T cell plus up to four additional ones with membrane extensions.)</s><s>we could demonstrate that this arrangement is recurring throughout the MF plaque at about 100 μ m intervals.The recurrences appear nearly identical to the example presented herein.</s><s>Re-inspecting the toponome analyses published earlier for psoriasis and atopic dermatitis, two pathological conditions mediated by T cells, and healthy skin <ref type="bibr" target="#b24">25</ref> , we found no evidence for SPIKE and the associated cell arrangement.</s><s>These structures appear to be specific for the MF plaque lesion.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>We suggest that the whole SPIKE motif shown here is expression of a supramolecular cell surface machinery enabling SPIKE to efficiently penetrate the BL barrier and mediate T cell piercing by suprabasal keratinocyte projections.</s><s>This machinery may be an efficient target for therapeutic intervention.</s><s>The CD8 motif-expressing non-tumour T cell in the dermis (Fig. <ref type="figure" target="#fig_2">3</ref>, Cell 5) is obviously not participating in the suprabasal cell extension of SPIKE, although it may be an important component of the overall SPIKE structure and function.</s><s>We have not observed any similar structure in normal skin or inflammatory skin conditions <ref type="bibr" target="#b24">25</ref> .</s><s>Together these findings suggest that SPIKE is a higher-order disease-specific multicellular unit in MF that mechanically connects epidermis and dermis (scheme Fig. <ref type="figure" target="#fig_5">4</ref>).</s><s>Mechanical entrapment of large numbers of T cells in MF skin may contribute to loss of    <ref type="table">1</ref>).</s><s>Bars in a, c:10 μ m; in d, e: 1 μ m local immune capacities <ref type="bibr" target="#b30">31</ref> .</s><s>Our findings demonstrate a high dimension of pathological cell interactions in cancer, here MF.</s><s>They show the complex immune contexture within the extended cancer tissue <ref type="bibr" target="#b36">37</ref> detected and dissected by direct microscopic in situ analyses with supramolecular to transcellular resolution for many cell types and molecular components simultaneously.</s><s>ICM and combinatorial geometry-based highly resolved identification of molecular networks and molecular nods in these networks may be exploited further for the identification of systems-based drug targets.</s><s>The potential efficacy of the successful blockade of such systems-based targets as therapeutic principle has been demonstrated earlier in other diseases <ref type="bibr" target="#b24">25</ref> .</s></p><p><s>In these studies, ICM has revealed that chronic diseases, when analyzed for many distinct cell surface-associated protein assemblies in parallel, have a unique supramolecular order in situ with protein hierarchies in which lead proteins control spatial protein network topology and function.</s><s>As shown before, inhibition of the lead proteins, e.g. in tumour cells results in disassembly of the corresponding protein clusters and loss of function <ref type="bibr" target="#b24">25</ref> .</s><s>Similar principles were demonstrated for amyothrophic lateral sclerosis (ALS) where CD16 (Fcgamma RIII) on human peripheral lymphocytes was identified as lead drug target <ref type="bibr" target="#b37">38</ref> This protein was then confirmed as potential ALS drug target in a FcgammaRIII KO mouse model <ref type="bibr" target="#b27">28</ref> and recently in a clinical phase II trial showing well tolerated downregulation of CD16 in ALS patients <ref type="bibr" target="#b28">29</ref> with a halt of disease progression in 27% of the patients <ref type="bibr" target="#b29">30</ref> .</s><s>This empirical verification supports the toponome hypothesis that lead proteins controlling in vivo protein network topology and (dys)function can be predictive drug targets in chronic diseases and that the combinatorial geometry of protein networks at the target sites of the disease, as shown in present study, can provide important functional information on disease mechanisms.</s></p><p><s>ICM-based target identification and decoding of disease mechanisms in situ may thus complement current strategies for discovery of checkpoint controls as therapeutic target for reconstitution or enhancement of T cell activity against cancer 2,6,7,15,39-43 .</s><s>The T cell trapping machinery may be a disease-specific robustness node for MF that ensures cancer progression by massively blocking cytotoxic T cells.</s><s>As such it may be a target for therapeutic interventions that restore efficient anti-tumour immune responses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Material and Methods</head><p><s>Skin tissue sections.</s><s>The protocol for the reported study had been carried out in strict accordance with the approved guidelines of the Institutional Ethics Committee of the Charité -Universitätsmedizin Berlin (EA1/157/08).</s><s>The skin tissue sections were selected from routine diagnostic dermatohistopathological procedures at the Department of Dermatology, Venerology and Allergology, Charité and used with written informed consent by the patients.</s><s>Skin biopsies were processed for formalin-fixed-paraffin-embedded (FFPE) histopathology or cryopreserved for ICM studies as described <ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b31">32</ref> .</s></p><p><s>Imaging cycler microscopy (ICM) and data processing.</s><s>An ICM robot (ToposNomos Ltd., Munich, Germany) was used to image random visual fields in frozen skin tissue sections at the dermo-epithelial junction, running robotically controlled, incubation -imaging -bleaching cycles on stage of an inverted epipfluorescence    microscope.</s><s>This can overcome the spectral resolution limit of the fluorescence microscope, as the number of cycles is principally not limited <ref type="bibr" target="#b24">25</ref> .</s><s>Briefly, here we used ICM to run cycles for the co-mapping of 25 cell surface-associated proteins together with histone/cytokeratin as markers for cellular nuclei/epithelial cells for orientation in a cryo-section of an MF skin lesion.</s><s>Antibodies/affinity reagents for co-mapping had been validated earlier <ref type="bibr" target="#b24">25</ref> .</s><s>Their specificity is listed in Supplementary Table <ref type="table">1</ref>.</s><s>Each cycle applies a specific FITC-conjugated antibody/affinity reagent recognizing and binding to a specific moiety in a preprogrammed sequence of robotic liquid handling on the sample of interest on stage.</s><s>Together the robotic process involves: removal of an FITC-conjugated antibody/affinity reagent (probe from a probe container), transfer of the probe onto the sample, removal of this probe after incubation, washing the sample repeatedly with buffer, and fluorescence imaging of the corresponding moiety -binding site in situ of the tissue section using a CCD camera, finally repeated buffer incubations while the fluorescence signal is bleached at the excitation wavelength (472 ± 15 nm) and endpoint images after bleaching are recorded, which finalized Cycle 1. Cycle 2 is then initiated with a FITC-conjugated probe with a second binding specificity and so forth.</s><s>Figure <ref type="figure" target="#fig_6">5</ref> shows the corresponding single-fluorescence signals per cycle of the tissue region displayed in Fig. <ref type="figure" target="#fig_7">1(c</ref>) by exemplifying the first fluorescence signals obtained in one optical plane out of 20 imaged in z-direction of the tissue in 200 nm steps (see below).</s><s>This was followed by a binarization step displaying each signal as absent or present (0/1) by using an expert-based <ref type="bibr" target="#b24">25</ref> and automated approach for threshold detection <ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b44">45</ref> (Fig. <ref type="figure" target="#fig_6">5b</ref>).</s><s>The resulting combinatorial co-map contained 7,161 different topological assemblies (combinatorial molecular phenotypes, CMPs) within the tissue area of interest (Fig. <ref type="figure" target="#fig_7">1b</ref>), where each pixel has a dimension of 200 nm × 200 nm (Supplementary Table <ref type="table">2</ref>).</s><s>These distinct biomolecular arrangements (CMPs) together lead to a large combinatorial geometric structure (Fig. <ref type="figure" target="#fig_6">5c</ref>, all CMPs) here referred to as binary 2D toponome map, in which distinct CMPs are displayed in different colors.</s><s>For exemplified CMP annotation within this geometric structure see Fig. <ref type="figure" target="#fig_6">5d</ref>.</s><s>This method and proofs of specificity and selectivity of the mapping procedure has been described earlier <ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b47">48</ref> , and its use for biomarker detection has been validated experimentally <ref type="bibr" target="#b24">25</ref> and clinically <ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b37">38,</ref><ref type="bibr" target="#b48">49</ref> .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ICM similarity mapping (SIM).</head><p><s>Besides the above described threshold-based method we applied a second, non-threshold-based method, called similarity mapping <ref type="bibr" target="#b34">35,</ref><ref type="bibr" target="#b35">36</ref> to extract the complete depth of information contained in multi-molecular assemblies at specific tissue sites (Fig. <ref type="figure" target="#fig_3">3a,b</ref>).</s><s>Briefly, the SIM method can compute the similarity/dissimilarity of the expression profiles of co-mapped biomolecules at any pixel of an ICM image data set.</s><s>By navigating through the ICM tissue structures of the 25-component ICM image data set, SIM identifies mutually exclusive biomolecular profiles, which highlight sharp edged selectivity of cellular tissue structures (Fig. <ref type="figure" target="#fig_3">3b</ref>; Supplementary Video 2).</s><s>This is achieved by modern graphics processing unit (GPU) methods computing similarity and dissimilarity of all pixels at any time during user selected cursor movements across the 25-component ICM image.</s><s>It is also possible to highlight distinct biomolecular profiles with different colors for direct interrogation of their tissue location as illustrated in Supplementary Video 2, which refers to the tissue area shown in Fig. <ref type="figure" target="#fig_7">1c</ref>.</s><s>This approach allowed us to determine protein profiles at the cell surfaces of SPIKE (Fig. <ref type="figure" target="#fig_3">3a</ref>) and thereby precisely annotate the cell types forming the SPIKE multicellular assembly (Fig. <ref type="figure" target="#fig_3">3a,b</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>3D colocation mapping.</head><p><s>For each optical plane of a z-stack the blur was computed and removed by using deconvolution software Huygens (Scientific Volume Imaging B.V., Hilversum, Netherlands).</s><s>Further, the software Imaris (Bitplane AG, Zurich, Switzerland) was used for 3D co-mapping of the deconvoluted images.</s><s>For generating 3D CMP data sets, we then applied expert-based or algorithm-based automated methods (see above) for determining gray value thresholds in each deconvoluted fluorescence signal of the 3D data set.</s><s>The resulting binary fluorescence images were used to compute the corresponding CMPs.</s><s>Display of these CMPs as 3D volume and quantitation of the resulting 3D CMPs was achieved by using the in-house software MultiCompare.</s><s>(Supplementary Video 3).</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Tissue organisation of SPIKE.</s><s>(a) 3D co-mapping of 3,213 CMPs (out of 7,161 CMPs) within an area of a MF skin tissue cryo-section (b) boxed area.</s><s>Distinct CMPs are visualised by different colors.</s><s>(b) phase contrast image of a cryo-preserved skin section of MF, in which nuclei were stained in blue for histone and the basal lamina in white for CD49f 24,25 (c) magnification of the boxed area of (b) in direct alignment with (d) locating the lead proteins of the CMPs shown in (a) uncovering SPIKE as an elongated multicellular arrangement of five cell types (Cells 1 to 5 in a,d,c).</s><s>A partial list of color decoding is given in Supplementary</s></p></div></figDesc><graphic coords="2,155.64,46.50,261.12,612.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Crosslinking of suprabasal non-tumour CD8 T cells by keratinocyte extensions.</s><s>(a) Overview of the wider area of the section detailed in Fig. 1.</s><s>(b) magnification of the boxed area in a.</s><s>The surface-rendered cytokeratin network of keratinocyte extensions are displayed in green, the T cells 2 and 6 in brown.</s><s>The white line traces the keratinocyte extensions through the T cells.</s><s>(c) same area as in b with display of the T cells in brown and the trace of the keratinocyte extensions as white line showing how the T cells are crosslinked by the extensions.</s><s>(d) magnification of boxed area in (b) showing details of the penetrated CD3 + CD8 + T cell 6.</s><s>Note that the CK-positive network penetrating and crosslinking T cells originates at the suprabasal site of SPIKE´s multicellular assembly (a, Cell 2) as illustrated in Fig. 1.</s><s>Bars: 10 μ m.</s></p></div></figDesc><graphic coords="4,155.64,46.50,396.00,325.92" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. Supramolecular organisation of SPIKE.</s><s>SPIKE as in Fig. 1a is depicted without the suprabasal Cells 1 and 2 to dissect its supramolecular cell surface organization by direct alignment of different methods.</s><s>(a) 3D structure of SPIKE as seen by co-mapping 3,213 distinct CMPs listed in Supplementary Table3and displayed in colors in part decoded in Supplementary Figure 2. (b) protein profiling by real-time similarity mapping (Supplementary Video 2) shows that Cell 5 has a variable CD8 + T cell profile while Cells 3 and 4 display variable HLA-DQ + profiles.</s><s>Note that the expression profile of the cell extension (a, arrow) at the site where it penetrates the BL (compare with c, arrow) is different from that of the Cell 3. (c) Semitransparent volume-rendered SPIKE showing a co-map of HLA-DQ (magenta) and HLA-DR (violet).</s><s>The basal lamina is marked by CD49f (white); (d) detail of the suprabasal section of the cell extension displaying overlaid expression of volume-rendered HLA-DQ/HLA-DR (transparent, colors as in c) together with CD29 in green, CD26 in pink and direct overlays of these molecules with CD44 in red; (e) magnification of the cell extension shown in (a) boxed area displaying its supramolecular CMP cell surface structure.</s><s>The direct real time decoding is shown in Supplementary Video 3; (f) list of co-mapped biomolecules (detailed in Supplementary Table1).</s><s>Bars in a, c:10 μ m; in d, e: 1 μ m</s></p></div></figDesc><graphic coords="5,98.64,46.50,456.00,270.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>3</head><label>3</label><figDesc><div><p><s>Figure 3. Supramolecular organisation of SPIKE.</s><s>SPIKE as in Fig. 1a is depicted without the suprabasal Cells 1 and 2 to dissect its supramolecular cell surface organization by direct alignment of different methods.</s><s>(a) 3D structure of SPIKE as seen by co-mapping 3,213 distinct CMPs listed in Supplementary Table3and displayed in colors in part decoded in Supplementary Figure 2. (b) protein profiling by real-time similarity mapping (Supplementary Video 2) shows that Cell 5 has a variable CD8 + T cell profile while Cells 3 and 4 display variable HLA-DQ + profiles.</s><s>Note that the expression profile of the cell extension (a, arrow) at the site where it penetrates the BL (compare with c, arrow) is different from that of the Cell 3. (c) Semitransparent volume-rendered SPIKE showing a co-map of HLA-DQ (magenta) and HLA-DR (violet).</s><s>The basal lamina is marked by CD49f (white); (d) detail of the suprabasal section of the cell extension displaying overlaid expression of volume-rendered HLA-DQ/HLA-DR (transparent, colors as in c) together with CD29 in green, CD26 in pink and direct overlays of these molecules with CD44 in red; (e) magnification of the cell extension shown in (a) boxed area displaying its supramolecular CMP cell surface structure.</s><s>The direct real time decoding is shown in Supplementary Video 3; (f) list of co-mapped biomolecules (detailed in Supplementary Table1).</s><s>Bars in a, c:10 μ m; in d, e: 1 μ m</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head></head><label></label><figDesc><div><p><s>Figure 3. Supramolecular organisation of SPIKE.</s><s>SPIKE as in Fig. 1a is depicted without the suprabasal Cells 1 and 2 to dissect its supramolecular cell surface organization by direct alignment of different methods.</s><s>(a) 3D structure of SPIKE as seen by co-mapping 3,213 distinct CMPs listed in Supplementary Table3and displayed in colors in part decoded in Supplementary Figure 2. (b) protein profiling by real-time similarity mapping (Supplementary Video 2) shows that Cell 5 has a variable CD8 + T cell profile while Cells 3 and 4 display variable HLA-DQ + profiles.</s><s>Note that the expression profile of the cell extension (a, arrow) at the site where it penetrates the BL (compare with c, arrow) is different from that of the Cell 3. (c) Semitransparent volume-rendered SPIKE showing a co-map of HLA-DQ (magenta) and HLA-DR (violet).</s><s>The basal lamina is marked by CD49f (white); (d) detail of the suprabasal section of the cell extension displaying overlaid expression of volume-rendered HLA-DQ/HLA-DR (transparent, colors as in c) together with CD29 in green, CD26 in pink and direct overlays of these molecules with CD44 in red; (e) magnification of the cell extension shown in (a) boxed area displaying its supramolecular CMP cell surface structure.</s><s>The direct real time decoding is shown in Supplementary Video 3; (f) list of co-mapped biomolecules (detailed in Supplementary Table1).</s><s>Bars in a, c:10 μ m; in d, e: 1 μ m</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4. Model for SPIKE.</s><s>Multicellular assembly in the dermis projects a long cell extension across the basal lamina into the epidermis where it interacts with an infiltrating non tumour CD8 T cell and a neighboring keratinocyte.</s><s>This interaction induces keratinocyte projections penetrating and crosslinking CD8 + T cells, thereby mechanically preventing them from (anti-tumour) action.</s><s>Brown: CD8 + CD3 + , green: cytokeratin; magenta: HLA-DQ as markers for the interacting cells.</s></p></div></figDesc><graphic coords="6,155.64,46.50,240.00,247.08" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 5 .</head><label>5</label><figDesc><div><p><s>Figure 5. Illustration of the cyclical localization of 25 biomolecules and construction of combinatorial geometry map.</s><s>(a) One optical plane out of 20 co-mapped planes in the z direction is shown to illustrate the fluorescence signals of the indicated biomolecules as in Supplementary Table1.</s><s>The visual field corresponds to the visual field shown in Fig. 1c.</s><s>(b) binarization of the primary signals from (a) displayed parallel to (a).</s><s>(c) 2D map of the combinatorial molecular phenotypes (CMPs) for all data points computed from the binary data set of (b).</s><s>(d) two example CMPs from the data points in (b) indicated in red and blue, respectively, corresponding to the colored boxes in (b).</s><s>See Supplementary Video 4 for the scheme of CMP detection and Supplementary Video 3 for realtime 3D SPIKE interrogation.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>1</head><label>1</label><figDesc><div><p><s>Figure 5. Illustration of the cyclical localization of 25 biomolecules and construction of combinatorial geometry map.</s><s>(a) One optical plane out of 20 co-mapped planes in the z direction is shown to illustrate the fluorescence signals of the indicated biomolecules as in Supplementary Table1.</s><s>The visual field corresponds to the visual field shown in Fig. 1c.</s><s>(b) binarization of the primary signals from (a) displayed parallel to (a).</s><s>(c) 2D map of the combinatorial molecular phenotypes (CMPs) for all data points computed from the binary data set of (b).</s><s>(d) two example CMPs from the data points in (b) indicated in red and blue, respectively, corresponding to the colored boxes in (b).</s><s>See Supplementary Video 4 for the scheme of CMP detection and Supplementary Video 3 for realtime 3D SPIKE interrogation.</s></p></div></figDesc><graphic coords="7,155.64,46.50,300.00,576.48" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head></head><label></label><figDesc><div><p><s>Figure 5. Illustration of the cyclical localization of 25 biomolecules and construction of combinatorial geometry map.</s><s>(a) One optical plane out of 20 co-mapped planes in the z direction is shown to illustrate the fluorescence signals of the indicated biomolecules as in Supplementary Table1.</s><s>The visual field corresponds to the visual field shown in Fig. 1c.</s><s>(b) binarization of the primary signals from (a) displayed parallel to (a).</s><s>(c) 2D map of the combinatorial molecular phenotypes (CMPs) for all data points computed from the binary data set of (b).</s><s>(d) two example CMPs from the data points in (b) indicated in red and blue, respectively, corresponding to the colored boxes in (b).</s><s>See Supplementary Video 4 for the scheme of CMP detection and Supplementary Video 3 for realtime 3D SPIKE interrogation.</s></p></div></figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Scientific RepoRts | 6:19012 | DOI: 10.1038/srep19012</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>Supported by the Klaus Tschira Foundation (KTS), Deutsche Forschungsgemeinschaft (DFG Schu627/10-1), BMBF (grants CELLECT, NBL3, NGFN2, and NGFNplus), DFG-Innovationskolleg (INK15), EU IMAGINT (Health-F5-2011-259881), Human Toponome Project (www.huto.toposnomos.com),</s><s>and the Berliner Krebsgesellschaft (WAFF2000824).</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Contributions</head><p><s>R.H. analyzed the ICM data in close cooperation with W.S. following the concept of ICM hypothesis-free systems microscopy; A.G. performed tissue preparation, cryo-sectioning and antibody-dye conjugation for ICM; A.K. programmed the ICM for the automated cyclical imaging in close cooperation with A.G. and W.S. D.H. and W.St. provided the clinical material and background information, and participated to the interpretation of the results.</s><s>H.J.R.H. contributed the histopathological diagnosis and assisted in the correlation of histopathology and ICM images.</s><s>P.W. contributed immunological and molecular biological background data and concepts, coordinated the collaboration and integration of the clinical, translational and molecular imaging groups, and participated in the interpretation of the results and the writing of the manuscript.</s><s>W.S. invented ICM, designed the study and drafted the manuscript, which was then finalized together with the co-authors.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Additional Information</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer</title>
		<author>
			<persName><forename type="first">G</forename><surname>Bindea</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.immuni.2013.10.003</idno>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="782" to="795" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Safety and activity of anti-PD-L1 antibody in patients with advanced cancer</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Brahmer</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa1200694</idno>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">366</biblScope>
			<biblScope unit="page" from="2455" to="2465" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Expression of tumour-specific antigens underlies cancer immunoediting</title>
		<author>
			<persName><forename type="first">M</forename><surname>Dupage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mazumdar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Jacks</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature10803</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">482</biblScope>
			<biblScope unit="page" from="405" to="409" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Type, density, and location of immune cells within human colorectal tumors predict clinical outcome</title>
		<author>
			<persName><forename type="first">J</forename><surname>Galon</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1129139</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">313</biblScope>
			<date type="published" when="1960">1960-1964 (2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Programmed cell death 1 ligand 1 and tumor-infiltrating CD81 T lymphocytes are prognostic factors of human ovarian cancer</title>
		<author>
			<persName><forename type="first">J</forename><surname>Hamanishi</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0611533104</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="3360" to="3365" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Improved survival with ipilimumab in patients with metastatic melanoma</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Hodi</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa1003466</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">363</biblScope>
			<biblScope unit="page" from="711" to="723" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Enhancement of antitumor immunity by CTLA-4 blockade</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Leach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Krummel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Allison</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.271.5256.1734</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">271</biblScope>
			<biblScope unit="page" from="1734" to="1736" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Mahmoud</surname></persName>
		</author>
		<idno type="DOI">10.1200/JCO.2010.30.5037</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<date type="published" when="1949">1949-1955 (2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting</title>
		<author>
			<persName><forename type="first">H</forename><surname>Matsushita</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature10755</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">482</biblScope>
			<biblScope unit="page" from="400" to="404" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Oble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Loewe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Mihm</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Immun</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">3</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer</title>
		<author>
			<persName><forename type="first">F</forename><surname>Page's</surname></persName>
		</author>
		<idno type="DOI">10.1200/JCO.2008.19.6147</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="5944" to="5951" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors</title>
		<author>
			<persName><forename type="first">S</forename><surname>Rusakiewicz</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.CAN-13-0371</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="3499" to="3510" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Cancer immunoediting: integrating immunity&apos;s roles in cancer suppression and promotion</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Schreiber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Old</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Smyth</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1203486</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">331</biblScope>
			<biblScope unit="page" from="1565" to="1570" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Stumpf</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.bjc.6605274</idno>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="1513" to="1521" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Safety, activity, and immune correlates of anti-PD-1 antibody in cancer</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Topalian</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa1200690</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">366</biblScope>
			<biblScope unit="page" from="2443" to="2454" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">In vivo discovery of immunotherapy targets in the tumour microenvironment</title>
		<author>
			<persName><forename type="first">P</forename><surname>Zhou</surname></persName>
		</author>
		<idno>doi: 10.1038/ nature12988</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">506</biblScope>
			<biblScope unit="page" from="52" to="57" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Peske</surname></persName>
		</author>
		<idno type="DOI">10.1038/ncomms8114</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">7114</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Myeloid-derived suppressor cells as regulators of the immune system</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">I</forename><surname>Gabrilovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nagaraj</surname></persName>
		</author>
		<idno type="DOI">10.1038/nri2506</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="162" to="174" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Immune microenvironments in solid tumors: new targets for therapy</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Shiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Ganesan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Rugo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Coussens</surname></persName>
		</author>
		<idno type="DOI">10.1101/gad.169029.111</idno>
	</analytic>
	<monogr>
		<title level="j">Genes Dev</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="2559" to="2572" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance</title>
		<author>
			<persName><forename type="first">C</forename><surname>Tanchot</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12307-012-0122-y</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Microenviron</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="147" to="157" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Tackling the cancer stem cells -what challenges do they pose?</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Pattabiraman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Weinberg</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrd4253</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Drug Discov</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="497" to="512" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer</title>
		<author>
			<persName><forename type="first">S</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Walden</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.imlet.2007.11.012</idno>
	</analytic>
	<monogr>
		<title level="j">Immunol Lett</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="7" to="14" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">High drug attrition rates--where are we going wrong?</title>
		<author>
			<persName><forename type="first">L</forename><surname>Hutchinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kirk</surname></persName>
		</author>
		<idno>doi: 10.1038/ nrclinonc.2011.34</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="189" to="190" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Buffered Qualitative Stability explains the robustness and evolvability of transcriptional networks</title>
		<author>
			<persName><forename type="first">L</forename><surname>Albergante</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Blow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Newman</surname></persName>
		</author>
		<idno type="DOI">10.7554/eLife.02863</idno>
	</analytic>
	<monogr>
		<title level="j">Elife</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">e02863</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Analyzing proteome topology and function by automated multidimensional fluorescence microscopy</title>
		<author>
			<persName><forename type="first">W</forename><surname>Schubert</surname></persName>
		</author>
		<idno type="DOI">10.1038/nbt1250</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1270" to="1278" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Systematic, spatial imaging of large multimolecular assemblies and the emerging principles of supramolecular order in biological systems</title>
		<author>
			<persName><forename type="first">W</forename><surname>Schubert</surname></persName>
		</author>
		<idno type="DOI">10.1002/jmr.2326</idno>
	</analytic>
	<monogr>
		<title level="j">J Mol Recognit</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="3" to="18" />
			<date type="published" when="2014">2014. 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Topological proteomics, toponomics, MELK-technology</title>
		<author>
			<persName><forename type="first">W</forename><surname>Schubert</surname></persName>
		</author>
		<idno type="DOI">10.1007/b11117</idno>
	</analytic>
	<monogr>
		<title level="j">Adv Biochem Eng Biotechnol</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="189" to="209" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Mohamed</surname></persName>
		</author>
		<idno type="DOI">10.1002/jnr.10271</idno>
	</analytic>
	<monogr>
		<title level="j">J Neurosci Res</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="110" to="116" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">NP001 regulation of macrophage activation markers in ALS: A phase I clinical and biomarker study</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Miller</surname></persName>
		</author>
		<idno type="DOI">10.3109/21678421.2014.951940</idno>
	</analytic>
	<monogr>
		<title level="j">Amyotroph Lateral Scler Frontotemporal Degener</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="601" to="609" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Goyal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mozaffar</surname></persName>
		</author>
		<idno type="DOI">10.1517/13543784.2014.933807</idno>
	</analytic>
	<monogr>
		<title level="j">Expert Opin Investig Drugs</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1541" to="1551" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Regulatory T cells and immunodefiency in mycosis fungoides and Szezary Syndrome</title>
		<author>
			<persName><forename type="first">T</forename><surname>Krejsgaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Odum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Geisler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Wasik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Woetmann</surname></persName>
		</author>
		<idno type="DOI">10.1038/leu.2011.237</idno>
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="424" to="432" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Fluorescence detection of protein clusters in individual cells and tissue sections by using toponome imaging system: sample preparation and measuring procedures</title>
		<author>
			<persName><forename type="first">M</forename><surname>Friedenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bode</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Krusche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Schubert</surname></persName>
		</author>
		<idno type="DOI">10.1038/nprot.2007.320</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Protoc</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="2285" to="2294" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<author>
			<persName><forename type="first">W</forename><surname>Schubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Dubitzky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Wolkenhauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yokota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Cho</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-1-4419-9863-7_631.ISBN978-1-4419-9862-0</idno>
		<title level="m">Toponomics in Encyclopedia of Systems Biology</title>
				<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<publisher>Springer</publisher>
			<date type="published" when="2013">2013</date>
			<biblScope unit="page" from="2191" to="2212" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Anti-tumor immune responses and tumor regression induced with mimotopes of a tumor-associated T cell epitope</title>
		<author>
			<persName><forename type="first">S</forename><surname>Tumenjargal</surname></persName>
		</author>
		<idno type="DOI">10.1002/eji.200324244</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="3175" to="3185" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W M</forename><surname>Dress</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lokot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Schubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename></persName>
		</author>
		<idno type="DOI">10.1007/s00026-004-0234-2</idno>
	</analytic>
	<monogr>
		<title level="j">Poisson Numbers and Poisson Distributions in Subset Surprisology. Ann Comb</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="473" to="485" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W M</forename><surname>Dress</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lokot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Schubert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">&amp; Serocka P. Two Theorems about Similarity Maps. Ann Comb</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="279" to="290" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Catherine Sautès-Fridman C. &amp; Galon J. The immune contexture in human tumours: impact on clinical outcome</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Fridman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Pagès</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrc3245</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="298" to="306" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<monogr>
		<title level="m" type="main">Method of blocking cytotoxic activity in patients with amyotrophic lateral sclerosis using antibodies to Fcγ RIII. United States patent US 6,638,506</title>
		<author>
			<persName><forename type="first">W</forename><surname>Schubert</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1999">2003 Oct 28. 1999</date>
		</imprint>
	</monogr>
	<note>first published as international patent application WO 99/29731</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Adoptive T cell therapy of cancer</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Brenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Heslop</surname></persName>
		</author>
		<idno>doi: 10.1016/j. coi.2010.01.020</idno>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Immunol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="251" to="257" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Curran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Montalvo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yagita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Allison</surname></persName>
		</author>
		<idno>doi: 10.1073/ pnas.0915174107</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="4275" to="4280" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kalos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>June</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.immuni.2013.07.002</idno>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="49" to="60" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Engineered T cells for anticancer therapy</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Turtle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hudecek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Riddell</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.coi.2010.01.020</idno>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Immunol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="633" to="639" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Adoptive immunotherapy for cancer: harnessing the T cell response</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Restifo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Dudley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rosenberg</surname></persName>
		</author>
		<idno type="DOI">10.1038/nri3191</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="269" to="281" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">An information theoretic thresholding method for detecting protein colocalizations in stacks of fluorescence images</title>
		<author>
			<persName><forename type="first">A</forename><surname>Barysenka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Dress</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Schubert</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jbiotec.2010.01.009</idno>
	</analytic>
	<monogr>
		<title level="j">J Biotechnol</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="127" to="131" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">A New Criterion for Automatic Multilevel Thresholding</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Yen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chang</surname></persName>
		</author>
		<idno type="DOI">10.1109/83.366472</idno>
	</analytic>
	<monogr>
		<title level="j">IEEE Trans Image Process</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="370" to="378" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<monogr>
		<title level="m" type="main">Method of blocking cytotoxic activity in patients with amyotrophic lateral sclerosis using protein V. United States patent US 6,638,515</title>
		<author>
			<persName><forename type="first">W</forename><surname>Schubert</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1999">2003 Oct 28. 1999</date>
		</imprint>
	</monogr>
	<note>first published as international patent application WO 99/29731</note>
</biblStruct>

<biblStruct xml:id="b46">
	<monogr>
		<title level="m" type="main">Method of blocking cytotoxic activity in patients with amyotrophic lateral sclerosis using soluble Fcγ RIII receptors. United States patent US 6,649,165</title>
		<author>
			<persName><forename type="first">W</forename><surname>Schubert</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1999">2003 Nov 18. 1999</date>
		</imprint>
	</monogr>
	<note>first published as international patent application WO 99/29731</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Next-generation biomarkers based on 100-parameter functional superresolution microscopy TIS</title>
		<author>
			<persName><forename type="first">W</forename><surname>Schubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gieseler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Krusche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Serocka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hillert</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nbt.2011.12.004</idno>
	</analytic>
	<monogr>
		<title level="j">N Biotechnol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="599" to="610" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Advances in toponomics drug discovery: Imaging cycler microscopy correctly predicts a therapy method of amyotrophic lateral sclerosis</title>
		<author>
			<persName><forename type="first">W</forename><surname>Schubert</surname></persName>
		</author>
		<idno type="DOI">10.1002/cyto.a.22671</idno>
	</analytic>
	<monogr>
		<title level="j">Cytometry A</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="696" to="703" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
